Contents

Current Drug Targets - Inflammation & Allergy, Volume 1 - Number 2

The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities

, 1(2): 127 - 136

Leonard Buckbinder and Ralph P. Robinson


DOI: 10.2174/1568010023344751




Upstream Signal Transduction of NF-κB Activation

, 1(2): 137 - 149

Fei Chen, Laurence M. Demers and Xianglin Shi


DOI: 10.2174/1568010023344706




Current and Future Therapeutic Strategies to Target Inflammation in Stroke

, 1(2): 151 - 166

Wandong Zhang and Danica Stanimirovic


DOI: 10.2174/1568010023344689




Mechanisms of Antihistamines and Mast Cell Stabilizers in Ocular Allergic Inflammation

, 1(2): 167 - 180

E.B. Cook, J.L. Stahl and F.M. Graziano


DOI: 10.2174/1568010023344733




Toll-Like Receptors and Inflammation in the CNS

, 1(2): 181 - 191

Sung Joong Lee and Soojin Lee


DOI: 10.2174/1568010023344698




Cytokines in Dementias

, 1(2): 193 - 200

Elisabeth Tarkowski


DOI: 10.2174/1568010023344670




Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease

, 1(2): 201 - 214

E.M. Erin, T.J. Williams, P.J. Barnes and T.T. Hansel


DOI: 10.2174/1568010023344715




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science